Treatment of choroidal melanoma-associated exudative retinal detachments with a dexamethasone intravitreal implant prior to proton beam radiation | Synapse
March 3, 2026
Treatment of choroidal melanoma-associated exudative retinal detachments with a dexamethasone intravitreal implant prior to proton beam radiation
Key Points
No improved clinical outcomes were observed following the use of dexamethasone implant.
Safety concerns were not identified in the cohort treated with dexamethasone.
Treatment involved the use of a dexamethasone intravitreal implant prior to proton radiation.
Findings suggest that the dexamethasone intervention may have limited therapeutic impact.
Abstract
Improved clinical outcomes were not observed in patients receiving the dexamethasone implant prior to proton radiation. No new safety concerns were identified with the use of dexamethasone in this cohort.